Ex-Bristol-Myers executive admits to insider trade
June 10, 2013 at 15:40 PM EDT
Robert Ramnarine, who was involved with evaluating potential acquisition targets for Bristol-Myers Squibb, admitted to illicit gains from trading in stock options of several of the pharmaceutical company’s targets.